アイスランド -
アイスランド語 -
LYFJASTOFNUN (Icelandic Medicines Agency)
zinacef stungulyfs-/innrennslisstofn, lausn 1,5 g
sandoz a/s - cefuroximum natríum - stungulyfs-/innrennslisstofn, lausn - 1,5 g
アイスランド -
アイスランド語 -
LYFJASTOFNUN (Icelandic Medicines Agency)
zinacef stungulyfs-/innrennslisstofn, lausn 750 mg
sandoz a/s - cefuroximum natríum - stungulyfs-/innrennslisstofn, lausn - 750 mg
アイスランド -
アイスランド語 -
LYFJASTOFNUN (Icelandic Medicines Agency)
eligard stungulyfsstofn og leysir, lausn 7,5 mg
recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 7,5 mg
アイスランド -
アイスランド語 -
LYFJASTOFNUN (Icelandic Medicines Agency)
eligard stungulyfsstofn og leysir, lausn 45 mg
recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 45 mg
アイスランド -
アイスランド語 -
LYFJASTOFNUN (Icelandic Medicines Agency)
eligard stungulyfsstofn og leysir, lausn 22,5 mg
recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 22,5 mg
欧州連合 -
アイスランド語 -
EMA (European Medicines Agency)
arexvy
glaxosmithkline biologicals s.a. - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - sýkingar af völdum sýklalyfja - bóluefni - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. notkun þetta bóluefni ætti að vera í samræmi við opinbera tillögur.
欧州連合 -
アイスランド語 -
EMA (European Medicines Agency)
kanuma
alexion europe sas - sebelipasa alfa - lipid efnaskipti, innfelldar villur - Önnur meltingarvegi og efnaskipti vörur, - kanuma er ætlað til langtímameðferð með ensímuppbótarmeðferð (ert) hjá sjúklingum á öllum aldri, með skort á lysósölt sýru lípasa (lal).
アイスランド -
アイスランド語 -
LYFJASTOFNUN (Icelandic Medicines Agency)
cutaquig stungulyf, lausn 165 mg/ml
octapharma ab - immunoglobulinum humanum inn - stungulyf, lausn - 165 mg/ml
欧州連合 -
アイスランド語 -
EMA (European Medicines Agency)
librela
zoetis belgium - bedinvetmab - verkjalyf - hundar - for the alleviation of pain associated with osteoarthritis in dogs.
欧州連合 -
アイスランド語 -
EMA (European Medicines Agency)
solensia
zoetis belgium sa - frunevetmab - verkjalyf - kettir - for the alleviation of pain associated with osteoarthritis in cats.